| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A clinical, histopathological, and molecular study of two cases of VEXAS syndrome without a definitive myeloid neoplasm
|
Li, Peng
|
|
|
6 |
2 |
p. 405-409
|
article
|
| 2 |
Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysis
|
Hamadani, Mehdi
|
|
|
6 |
2 |
p. 486-494
|
article
|
| 3 |
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis
|
Cuker, Adam
|
|
|
6 |
2 |
p. 664-671
|
article
|
| 4 |
A novel NUP98-JADE2 fusion in a patient with acute myeloid leukemia resembling acute promyelocytic leukemia
|
Cheng, Chi-Keung
|
|
|
6 |
2 |
p. 410-415
|
article
|
| 5 |
Anti–IL-6 cytokine treatment has no impact on elevated hematocrit or splenomegaly in a polycythemia vera mouse model
|
Baldauf, Conny K.
|
|
|
6 |
2 |
p. 399-404
|
article
|
| 6 |
Clonal phylogeny and evolution of critical cytogenetic aberrations in multiple myeloma at single-cell level by QM-FISH
|
Yan, Yuting
|
|
|
6 |
2 |
p. 441-451
|
article
|
| 7 |
Commentary on the ASH ISTH NHF WFH 2021 guidelines on the diagnosis of VWD: reflections based on recent contemporary test data
|
Favaloro, Emmanuel J.
|
|
|
6 |
2 |
p. 416-419
|
article
|
| 8 |
Cost-effectiveness of diagnostic strategies for venous thromboembolism: a systematic review
|
Zhang, Yuan
|
|
|
6 |
2 |
p. 544-567
|
article
|
| 9 |
CPX-351 induces remission in newly diagnosed pediatric secondary myeloid malignancies
|
Hu, Yixin
|
|
|
6 |
2 |
p. 521-527
|
article
|
| 10 |
Cytomegalovirus gastroenteritis in patients with acute graft-versus-host disease
|
Akahoshi, Yu
|
|
|
6 |
2 |
p. 574-584
|
article
|
| 11 |
Dasatinib-based 2-step induction for adults with Philadelphia chromosome–positive acute lymphoblastic leukemia
|
Sugiura, Isamu
|
|
|
6 |
2 |
p. 624-636
|
article
|
| 12 |
Editorial Board
|
|
|
|
6 |
2 |
p. i
|
article
|
| 13 |
Epidemiology and treatment patterns of idiopathic multicentric Castleman disease in the era of IL-6–directed therapy
|
Mukherjee, Sudipto
|
|
|
6 |
2 |
p. 359-367
|
article
|
| 14 |
Feasibility of high-dose methotrexate administered on day 1 of (R)CHOP in aggressive non-Hodgkin lymphomas
|
Fleming, Megan
|
|
|
6 |
2 |
p. 460-472
|
article
|
| 15 |
FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology
|
Botta, Cirino
|
|
|
6 |
2 |
p. 690-703
|
article
|
| 16 |
Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms
|
Alkhateeb, Hassan B.
|
|
|
6 |
2 |
p. 528-532
|
article
|
| 17 |
High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia
|
Dávila Saldaña, Blachy J.
|
|
|
6 |
2 |
p. 452-459
|
article
|
| 18 |
Idiopathic purpura fulminans associated with anti-protein S antibodies in children: a multicenter case series and systematic review
|
Theron, Alexandre
|
|
|
6 |
2 |
p. 495-502
|
article
|
| 19 |
Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study
|
Guglielmelli, Paola
|
|
|
6 |
2 |
p. 373-375
|
article
|
| 20 |
Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapy
|
Dahiya, Saurabh
|
|
|
6 |
2 |
p. 686-689
|
article
|
| 21 |
Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways
|
Witte, Hanno M.
|
|
|
6 |
2 |
p. 637-651
|
article
|
| 22 |
Laminin G1 residues of protein S mediate its TFPI cofactor function and are competitively regulated by C4BP
|
Teraz-Orosz, Adrienn
|
|
|
6 |
2 |
p. 704-715
|
article
|
| 23 |
MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma
|
Stroh, Jacob
|
|
|
6 |
2 |
p. 515-520
|
article
|
| 24 |
Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia
|
Balasundaram, Nithya
|
|
|
6 |
2 |
p. 652-663
|
article
|
| 25 |
Multiple myeloma cells depend on the DDI2/NRF1-mediated proteasome stress response for survival
|
Chen, Tianzeng
|
|
|
6 |
2 |
p. 429-440
|
article
|
| 26 |
Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine
|
Zátopková, Martina
|
|
|
6 |
2 |
p. 368-372
|
article
|
| 27 |
Origins of bloodstream infections following fecal microbiota transplantation: a strain-level analysis
|
Eshel, Adi
|
|
|
6 |
2 |
p. 568-573
|
article
|
| 28 |
Pevonedistat targets malignant cells in myeloproliferative neoplasms in vitro and in vivo via NFκB pathway inhibition
|
Kong, Tim
|
|
|
6 |
2 |
p. 611-623
|
article
|
| 29 |
Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: survival update and new extension cohort data
|
Sehn, Laurie H.
|
|
|
6 |
2 |
p. 533-543
|
article
|
| 30 |
Practice patterns and real-life outcomes for patients with acute promyelocytic leukemia in the United States
|
Bewersdorf, Jan Philipp
|
|
|
6 |
2 |
p. 376-385
|
article
|
| 31 |
Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma
|
Zinzani, Pier Luigi
|
|
|
6 |
2 |
p. 590-599
|
article
|
| 32 |
Single-cell sequencing demonstrates complex resistance landscape in CLL and MCL treated with BTK and BCL2 inhibitors
|
Thompson, Ella R.
|
|
|
6 |
2 |
p. 503-508
|
article
|
| 33 |
The ASH-ASPHO Choosing Wisely Campaign: 5 hematologic tests and treatments to question
|
O'Brien, Sarah H.
|
|
|
6 |
2 |
p. 679-685
|
article
|
| 34 |
The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11
|
Lafage-Pochitaloff, Marina
|
|
|
6 |
2 |
p. 386-398
|
article
|
| 35 |
Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report
|
Fabrizio, Vanessa A.
|
|
|
6 |
2 |
p. 600-610
|
article
|
| 36 |
Toll-like receptor 4 selective inhibition in medullar microenvironment alters multiple myeloma cell growth
|
Lemaitre, Léa
|
|
|
6 |
2 |
p. 672-678
|
article
|
| 37 |
Tumor-associated antigen–specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma
|
Dave, Hema
|
|
|
6 |
2 |
p. 473-485
|
article
|
| 38 |
Vesicular trafficking is a key determinant of the statin response in acute myeloid leukemia
|
Krosl, Jana
|
|
|
6 |
2 |
p. 509-514
|
article
|
| 39 |
VpreB surrogate light chain expression in B-lineage ALL: a report from the Children's Oncology Group
|
Winter, Stuart S.
|
|
|
6 |
2 |
p. 585-589
|
article
|
| 40 |
Whole-exome analysis of adolescents with low VWF and heavy menstrual bleeding identifies novel genetic associations
|
Sadler, Brooke
|
|
|
6 |
2 |
p. 420-428
|
article
|
Journal description